Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| LYFT Lyft, Inc. | Courtney Temple | Thom Tillis Member office · Republican-NC · 2015–2020 | Leg. Dir | Lyft | Report period 2025 Q2 ↗ Posted Oct 30, 2026 · in 2 filings |
| C Citigroup, Inc. | Ryan Adam | Thom Tillis Member office · Republican-NC · 2016–2026 | Staff Assistant | Citigroup Washington, Inc. | Report period 2026 Q3 ↗ Posted Oct 21, 2026 · in 3 filings |
| SM SM Energy Company | Kyle Sanders | Thom Tillis Member office · Republican-NC | Special Assistant for Economic Development/Deputy Chief of Staff | Thorn Run Partners | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 5 filings |
| MANE Veradermics, Incorporated | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 2 filings |
| TREE LendingTree, Inc. | Kyle Sanders | Thom Tillis Member office · Republican-NC | Special Assistant for Economic Development/Deputy Chief of Staff | Thorn Run Partners | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 3 filings |
| FSLR First Solar, Inc. | Kyle Sanders | Thom Tillis Member office · Republican-NC | Not stated | Thorn Run Partners | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 8 filings |
| BHVN Biohaven Ltd. | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 2 filings |
| ABBV AbbVie Inc. | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 19, 2026 · in 2 filings |
| PAHC Phibro Animal Health Corporation | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 16, 2026 · in 2 filings |
| REGN Regeneron Pharmaceuticals, Inc. | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 16, 2026 · in 2 filings |
| LLY Eli Lilly and Company | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 16, 2026 · in 2 filings |
| GSK GSK plc | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 2 filings |
| NVO Novo Nordisk A/S | Timothy Blanchat | Thom Tillis Member office · Republican-NC | Deputy State Director | Checkmate Government Relations | Report period 2026 Q3 ↗ Posted Oct 15, 2026 · in 2 filings |
| BMY Bristol-Myers Squibb Company | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q2 ↗ Posted Jul 20, 2026 · in 8 filings |
| TAK Takeda Pharmaceutical Company Limited | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| PM Philip Morris International Inc | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 8 filings |
| PFE Pfizer, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 5 filings |
| NVO Novo Nordisk A/S | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| NVS Novartis AG | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| MYGN Myriad Genetics, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| ILMN Illumina, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| JNJ Johnson & Johnson | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| PODD Insulet Corporation | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 5 filings |
| GILD Gilead Sciences, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| FOXA Fox Corporation Class A | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| EXEL Exelixis, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| LLY Eli Lilly and Company | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| CDNA CareDx, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 4 filings |
| BIIB Biogen Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| BDSX Biodesix, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| AZN AstraZeneca plc | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 4 filings |
| APO Apollo Global Management, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| AMGN Amgen Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALNY Alnylam Pharmaceuticals, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 7 filings |
| ALKS Alkermes plc | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2026 Q1 ↗ Posted Apr 20, 2026 · in 6 filings |
| TFC Truist Financial Corporation | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q4 ↗ Posted Apr 20, 2026 · in 7 filings |
| NLST Netlist, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q4 ↗ Posted Jan 17, 2026 · in 5 filings |
| LXRX Lexicon Pharmaceuticals, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q2 ↗ Posted Oct 15, 2025 · in 5 filings |
| NRXP NRX Pharmaceuticals, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q2 ↗ Posted Oct 12, 2025 · in 5 filings |
| GLXY Galaxy Digital Inc. | Jeffrey Williams | Thom Tillis Member office · Republican-NC · 2017–2018 | Counsel | Galaxy Digital Holdings LP | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 2 filings |
| MRK Merck & Company, Inc. | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 3 filings |
| MCK McKesson Corporation | Ted Lehman | Tillis (Senate) Member office · Senate | Chief of Staff | Todd Strategy Group | Report period 2025 Q1 ↗ Posted Apr 21, 2025 · in 3 filings |
| EBAY eBay Inc. | Kyle Sanders | Thom Tillis Member office · Republican-NC | Special Assistant for Economic Development/Deputy Chief of Staff | Thorn Run Partners | Report period 2024 Q4 ↗ Posted Jan 19, 2025 |
The newest 43 of 43 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 7:06 PM EST.